Sentara Infusion Services recalls NALBUPHINE (a) 1.5MG IN 1.5ML NS, (b) 2.5MG IN 2.5ML NS, SYRINGE, pain, Rx Only, Sentara Home Infusion Pharmacy Services
Recalled February 22, 2023 · FDA recall D-0311-2023 · Sentara Infusion Services
Hazard
Lack of sterility assurance · FDA Class II
Units
31 syringes
Sold at
Dispensed to Patients Nationwide.
Description
Lack of sterility assurance
Product
NALBUPHINE (a) 1.5MG IN 1.5ML NS, (b) 2.5MG IN 2.5ML NS, SYRINGE, pain, Rx Only, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320
Manufacturer(s)
Sentara Infusion Services
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →